Variant report
Variant | nsv594954 |
---|---|
Chromosome Location | chr4:102639502-102659750 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:290)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr4:102651772-102651979 | HepG2 | liver: | n/a | n/a |
2 | BATF | chr4:102651652-102651967 | GM12878 | blood: | n/a | n/a |
3 | BHLHE40 | chr4:102645420-102645722 | GM12878 | blood: | n/a | n/a |
4 | CBX3 | chr4:102651391-102652158 | HCT-116 | colon: | n/a | n/a |
5 | CEBPB | chr4:102648976-102649113 | IMR90 | lung: | n/a | n/a |
6 | CHD2 | chr4:102645300-102645668 | GM12878 | blood: | n/a | n/a |
7 | CTCF | chr4:102651735-102651947 | GM12891 | blood: | n/a | n/a |
8 | CTCF | chr4:102651820-102651970 | HPAF | blood vessel: | n/a | n/a |
9 | CTCF | chr4:102651780-102651930 | AG04449 | skin: | n/a | n/a |
10 | CTCF | chr4:102651764-102651960 | LNCaP | prostate: | n/a | n/a |
11 | CTCF | chr4:102653540-102653690 | HVMF | connective: | n/a | n/a |
12 | CTCF | chr4:102644084-102644127 | K562 | blood: | n/a | n/a |
13 | CTCF | chr4:102651695-102652052 | K562 | blood: | n/a | n/a |
14 | CTCF | chr4:102651728-102652014 | GM12878 | blood: | n/a | n/a |
15 | CTCF | chr4:102651768-102651904 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | CTCF | chr4:102651820-102651970 | Caco-2 | colon: | n/a | n/a |
17 | CTCF | chr4:102651800-102651950 | HEEpiC | esophagus: | n/a | n/a |
18 | CTCF | chr4:102651780-102651930 | AG10803 | skin: | n/a | n/a |
19 | CTCF | chr4:102651760-102651910 | HEK293 | kidney: | n/a | n/a |
20 | CTCF | chr4:102651705-102651973 | HepG2 | liver: | n/a | n/a |
21 | CTCF | chr4:102651800-102651950 | BJ | skin: | n/a | n/a |
22 | CTCF | chr4:102651460-102651610 | SAEC | small airway: | n/a | n/a |
23 | CTCF | chr4:102651760-102651910 | SAEC | small airway: | n/a | n/a |
24 | CTCF | chr4:102651800-102651950 | GM12866 | blood: | n/a | n/a |
25 | CTCF | chr4:102651780-102651930 | GM12878 | blood: | n/a | n/a |
26 | CTCF | chr4:102651760-102651910 | HRE | kidney: | n/a | n/a |
27 | CTCF | chr4:102651760-102651910 | GM12870 | blood: | n/a | n/a |
28 | CTCF | chr4:102651721-102651989 | ProgFib | skin: | n/a | n/a |
29 | CTCF | chr4:102651820-102651970 | GM12878 | blood: | n/a | n/a |
30 | CTCF | chr4:102651755-102651980 | GM13976 | blood: | n/a | n/a |
31 | CTCF | chr4:102651760-102651910 | WERI-Rb-1 | eye: | n/a | n/a |
32 | CTCF | chr4:102651820-102651970 | HMF | breast: | n/a | n/a |
33 | CTCF | chr4:102651780-102651930 | GM12873 | blood: | n/a | n/a |
34 | CTCF | chr4:102653380-102653530 | HVMF | connective: | n/a | n/a |
35 | CTCF | chr4:102651760-102651910 | HepG2 | liver: | n/a | n/a |
36 | CTCF | chr4:102651780-102651930 | GM12872 | blood: | n/a | n/a |
37 | CTCF | chr4:102651780-102651930 | HL-60 | blood: | n/a | n/a |
38 | CTCF | chr4:102651784-102651969 | LNCaP | prostate: | n/a | n/a |
39 | CTCF | chr4:102651729-102651962 | GM19240 | blood: | n/a | n/a |
40 | CTCF | chr4:102652020-102652170 | HFF-Myc | foreskin: | n/a | n/a |
41 | CTCF | chr4:102651748-102651987 | T-47D | breast: | n/a | n/a |
42 | CTCF | chr4:102651800-102651950 | HPF | lung: | n/a | n/a |
43 | CTCF | chr4:102651744-102651944 | MCF-7 | breast: | n/a | n/a |
44 | CTCF | chr4:102651780-102651930 | HMEC | breast: | n/a | n/a |
45 | CTCF | chr4:102651820-102651970 | GM12864 | blood: | n/a | n/a |
46 | CTCF | chr4:102651840-102651990 | HAc | cerebellar: | n/a | n/a |
47 | CTCF | chr4:102651752-102651942 | MCF-7 | breast: | n/a | n/a |
48 | CTCF | chr4:102651820-102651970 | HCT-116 | colon: | n/a | n/a |
49 | CTCF | chr4:102651820-102651970 | BE2_C | brain: | n/a | n/a |
50 | CTCF | chr4:102651780-102651930 | HAc | cerebellar: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-462P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536237168 | chr4:102640044-102640045 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs538555210 | chr4:102640084-102640085 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs148865701 | chr4:102640089-102640090 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs181963995 | chr4:102640189-102640190 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs115482692 | chr4:102640229-102640230 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs186795208 | chr4:102640256-102640257 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs189990731 | chr4:102640272-102640273 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs563036603 | chr4:102640273-102640274 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs562764958 | chr4:102640317-102640318 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs10433986 | chr4:102640341-102640342 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs541829701 | chr4:102640342-102640343 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs182166188 | chr4:102640359-102640360 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs79712596 | chr4:102640406-102640407 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs552260006 | chr4:102640425-102640426 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs180769385 | chr4:102640723-102640724 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs12501586 | chr4:102642012-102642013 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs530233313 | chr4:102642048-102642049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78729535 | chr4:102642052-102642053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548417633 | chr4:102642061-102642062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12648423 | chr4:102642073-102642074 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs530465735 | chr4:102642094-102642095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573437437 | chr4:102642117-102642118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552522171 | chr4:102642139-102642140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570778245 | chr4:102642173-102642174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144116097 | chr4:102642175-102642176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550303281 | chr4:102642205-102642206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs568618177 | chr4:102642221-102642222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183801638 | chr4:102642269-102642270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs372274944 | chr4:102642275-102642276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572285642 | chr4:102642289-102642290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12506451 | chr4:102642299-102642300 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs7660525 | chr4:102642344-102642345 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs575956113 | chr4:102642401-102642402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs10856962 | chr4:102642453-102642454 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs150682876 | chr4:102642455-102642456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116407414 | chr4:102642476-102642477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373195369 | chr4:102642502-102642503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12506517 | chr4:102642526-102642527 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs538517530 | chr4:102642535-102642536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565614527 | chr4:102642704-102642705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs138895076 | chr4:102642825-102642826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556930747 | chr4:102642881-102642882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527957346 | chr4:102642904-102642905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531125351 | chr4:102642958-102642959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368058422 | chr4:102642986-102642987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577705539 | chr4:102643064-102643065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564458967 | chr4:102643075-102643076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs531735704 | chr4:102643076-102643077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550240524 | chr4:102643098-102643099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs144780302 | chr4:102643156-102643157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
myeloid cancer | 21057493 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:102642000-102643800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr4:102645000-102645800 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr4:102645200-102645600 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
4 | chr4:102645200-102645600 | Enhancers | Primary T helper cells fromperipheralblood | blood |
5 | chr4:102645200-102645600 | Active TSS | Duodenum Mucosa | Duodenum |
6 | chr4:102645200-102645600 | Active TSS | Rectal Mucosa Donor 29 | rectum |
7 | chr4:102645200-102645800 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
8 | chr4:102645200-102645800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
9 | chr4:102645400-102645800 | Active TSS | Gastric | stomach |
10 | chr4:102645400-102645800 | Enhancers | Sigmoid Colon | Sigmoid Colon |
11 | chr4:102645800-102651200 | Weak transcription | Primary B cells from peripheral blood | blood |
12 | chr4:102651200-102652200 | Enhancers | Primary B cells from peripheral blood | blood |
13 | chr4:102651600-102652200 | Enhancers | A549 | lung |
14 | chr4:102651800-102652200 | Enhancers | Stomach Mucosa | stomach |
15 | chr4:102654600-102655000 | Enhancers | Adipose Nuclei | Adipose |
16 | chr4:102654600-102655800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |